Revance Therapeutics Inc (RVNC)
5.86
+0.06
(+1.03%)
USD |
NASDAQ |
Nov 05, 14:36
Revance Therapeutics EPS Estimates for Current Fiscal Year
EPS Estimates for Current Fiscal Year Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Estimates for Current Fiscal Year Data
Date | Value |
---|---|
October 15, 2024 | -- |
August 30, 2024 | -- |
August 12, 2024 | -- |
August 09, 2024 | -- |
May 12, 2024 | -- |
May 10, 2024 | -- |
February 29, 2024 | -- |
February 23, 2024 | -- |
February 21, 2024 | -- |
January 29, 2024 | -- |
January 10, 2024 | -- |
January 09, 2024 | -- |
January 08, 2024 | -- |
December 31, 2023 | -- |
November 29, 2023 | -- |
November 09, 2023 | -- |
November 06, 2023 | -- |
September 22, 2023 | -- |
September 21, 2023 | -- |
September 20, 2023 | -- |
August 16, 2023 | -- |
August 15, 2023 | -- |
August 09, 2023 | -- |
May 10, 2023 | -- |
March 10, 2023 | -- |
Date | Value |
---|---|
March 02, 2023 | -- |
March 01, 2023 | -- |
January 31, 2023 | -- |
January 26, 2023 | -- |
January 10, 2023 | -- |
January 09, 2023 | -- |
January 03, 2023 | -- |
December 31, 2022 | -- |
December 08, 2022 | -- |
November 09, 2022 | -- |
October 24, 2022 | -- |
October 21, 2022 | -- |
October 18, 2022 | -- |
October 14, 2022 | -- |
September 22, 2022 | -- |
September 15, 2022 | -- |
September 08, 2022 | -- |
August 25, 2022 | -- |
August 11, 2022 | -- |
August 10, 2022 | -- |
August 09, 2022 | -- |
May 11, 2022 | -- |
May 10, 2022 | -- |
March 21, 2022 | -- |
March 08, 2022 | -- |
Earnings Per Share Estimates Definition
This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.